Roche receives FDA clearance for next generation cobas MRSA/SA Test
Roxgold grants stock options and restricted stock units
Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology
Roxgold announces graduation to Tier 1 of the TSX Venture Exchange
Roxgold provides financing and project development update
Roche receives FDA Emergency Use Authorization for the LightMix® Ebola Zaire rRT-PCR Test
These quality funds with smaller asset bases have portfolios built around solid companies.
Large drugmakers are out of favor, but some good funds are banking on a rebound.
As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.